Are glucocorticoids or NSAIDs more effective in reducing idiopathic feline urinary tract disease signs than no treatment or placebo?

Published:

2021-08-12

Share
Open Access Logo

DOI

https://doi.org/10.18849/ve.v6i3.439

Abstract

There is an erratum to this paper published in Veterinary Evidence Vol 6, Issue 4 (2021): https://doi.org/10.18849/ve.v6i4.532

PICO question

In cats with idiopathic feline urinary tract disease (FLUTD), are glucocorticoid or non-steroidal anti-inflammatory drugs more effective than placebo or no treatment in reducing clinical signs attributable to cystitis?

 

Clinical bottom line

Category of research question

Treatment

The number and type of study designs reviewed

Three randomised controlled trials have examined the efficacy of prednisolone or non-steroidal anti-inflammatory drugs (NSAIDs) in reducing the clinical signs of feline lower urinary tract disease compared to a placebo whilst one retrospective cohort study compared the reoccurrence of FLUTD in cats treated with meloxicam and without meloxicam

Strength of evidence

Weak

Outcomes reported

One small controlled trial compared prednisolone to a placebo and found no clinical differences in dysuria, microscopic haematuria, and occult blood for cats diagnosed with idiopathic non-obstructive feline lower urinary tract disease (FLUTD) hospitalised for 10 days. The study however had a very small sample size. Furthermore, the external validity of the study to similar patients discharged to their home environment is unclear.

The second small controlled trial compared meloxicam to a placebo in cats diagnosed with obstructive FLUTD. Statistical analysis was applied to determine if there were significant differences in voiding behaviour, general demeanour, haematuria, food intake and abdominal pain as assessed by the veterinarians in charge during hospitalisation and owners at discharge. No statistically significant differences (P>0.05) were calculated between the two treatment groups based on the owner questionnaire and veterinarian assessment but small samples in each treatment probably limited statistical power.

The third small controlled trial compared the reoccurrence of feline idiopathic cystitis (FIC), related clinical signs and recurrent urinary obstruction in cats at 10 days, 1, 2 and 6 months after discharge when treated with phenoxybenzamine and alprazolam, with or without the addition of meloxicam. No statistically significant differences were found in the reoccurrence of obstructed or non-obstructed FIC for cats treated with either meloxicam or no meloxicam. However, full details of each intervention group were not sufficient to assess for balance of prognostic factors, subjective scoring of clinical signs was not detailed, and the study was underpowered for the actual obstruction rates reported.

The fourth paper was a retrospective cohort study that examined the association of different treatment factors with 30 days reobstruction. The study found no significant association between the use of meloxicam and the rate of reobstruction but a number of confounders were present

Conclusion

Three small randomised controlled trials and a single retrospective cohort study failed to find a significant association between the use of glucocorticoids or NSAIDs with severity of FLUTD clinical signs or risk of reobstruction. Clinical outcome measures were heterogeneous and studies were significantly underpowered and/or at risk for bias and/or confounding. There is insufficient evidence to recommend the use of either drug category in decreasing time to resolution or severity of clinical signs in cases of idiopathic FLUTD or FIC

 

How to apply this evidence in practice

The application of evidence into practice should take into account multiple factors, not limited to: individual clinical expertise, patient’s circumstances and owners’ values, country, location or clinic where you work, the individual case in front of you, the availability of therapies and resources.

Knowledge Summaries are a resource to help reinforce or inform decision making. They do not override the responsibility or judgement of the practitioner to do what is best for the animal in their care.

 

Open Access Peer Reviewed

References

Osborne, C.A., Kruger, J.M., Lulich, J.P., Johnston, G.R., Polzin, D.J., Ulrich, L.K. & Sanna, J. (1996). Prednisolone Therapy of Idiopathic Feline Lower Urinary Tract Disease. Veterinary Clinics of North America: Small Animal Practice. 26(3), 563–569. DOI: http://dx.doi.org/1016/s0195-5616(96)50085-9

Dorsch, R., Zellner, F., Schulz, B., Sauter-Louis, C. & Hartmann, K. (2016). Evaluation of meloxicam for the treatment of obstructive feline idiopathic cystitis. Journal of Feline Medicine and Surgery. 18(11), 925–933. DOI: https://doi.org/10.1177%2F1098612X15621603

Nivy, R., Segev, G., Rimer, D., Bruchim, Y., Aroch, I. & Mazaki-Tovi, M. (2019). A prospective randomized study of efficacy of 2 treatment protocols in preventing recurrence of clinical signs in 51 male cats with obstructive idiopathic cystitis. Journal of Veterinary Internal Medicine. 33(5), 2117–2123. DOI: http://doi.org/10.1111/jvim.15594

Hetrick, P. & Davidow, E.B. (2013). Initial treatment factors associated with feline urethral obstruction recurrence rate: 192 cases (2004–2021). Journal of American Veterinary Medical Association. 243(4), 512–519. DOI: http://dx.doi.org/2460/javma.243.4.512

Steckler, A. & McLeroy, K.R. (2008). The Importance of External Validity. American Journal of Public Health. 98(10), 09–10. DOI: http://dx.doi.org/10.2105/AJPH.2007.126847

Westropp, J.L., Kass, P.H. & Buffington, C.A.T. (2006). Evaluation of the effects of stress in cats with idiopathic cystitis. American Journal of Veterinary Research. 67(4), 731–736. DOI: http://dx.doi.org/ 2460/ajvr.67.4.731

McCobb, E.C., Patronek, G.J., Marder, A., Dinnage, J.D. & Stone, M.S. (2005). Assessment of stress levels among cats in four animal shelters. Journal of the American Veterinary Medical Association. 226(4), 548–555. DOI: http://dx.doi.org/ 2460/javma.2005.226.548

Jones, S.R., Carley, S. & Harrison, M. (2004). An introduction to power and sample size estimation. Emergency Medicine Journal. 20(5), 126. DOI: http://dx.doi.org/1136/emj.20.5.453

Banerjee, A., Chitnis, U.B., Jadhav, S.L., Bhawalkar, J.S. & Chaudhury, S. (2009). Hypothesis testing, type I and type II errors. Indian Psychiatry Journal. 18(2), 127–131. DOI: https://doi.org/10.4103/0972-6748.62274

Barasanti, J.A., Shotts, E.B., Crowell, W.A., Finco, D.R. & Brown, J. (1992). Effect of Therapy on Susceptibility to Urinary Tract Infection in Male Cats with Indwelling Urethral Catheters. Journal of Veterinary Internal Medicine. 6(2), 64–70. DOI: http://dx.doi.org/1111/j.1939-1676.1992.tb03153.x

Epstein, M.E., Rodanm, I., Griffenhagen, G., Kadrlik, J., Petty, M.C., Robertson, S.A. & Simpson, W. (2015). 2015 AAHA/AAFP Pain Management Guidelines for Dogs and Cats. Journal of Feline Medicine and Surgery. 17(3), 251–272. DOI: http://dx.doi.org/1177/1098612X15572062

Segev, G., Livne, H., Ranen, E. & Lavy, E. (2011). Urethral obstruction in cats: /predisposing factors, clinical, clinicopathological characteristics and prognosis. Journal of Feline Medicine and Surgery. 13(2), 101–108. DOI: http://dx.doi.org/1016/j.jfms.2010.10.006

Kim, Y., Kim, H., Pfeiffer, D. & Brodbelt, D. (2018). Epidemiological study of feline idiopathic cystitis in Seoul, South Korea. Journal of Feline Medicine and Surgery. 20(10), 913–921. DOI: http:/dx.doi.org/1177/1098612X17734067

Cameron, M.E., Casey, R.A., Bradshaw, J.W.S., Waran, N.K. & Gunn-Moore, D.A. (2004). A study of environmental and behavioural factors that may be associated with feline idiopathic cystitis. Journal of Small Animal Practice. 45(3), 144–47. DOI: http://dx.doi.org/10.1111/j.1748-5827.2004.tb00216.x

Vol. 6 No. 3 (2021): The third issue of 2021

Section: Knowledge Summaries

Categories :  Small Animal  /  Dogs  /  Cats  /  Rabbits  /  Production Animal  /  Cattle  /  Sheep  /  Pig  /  Equine  /  Exotics  /